Top

Published in:

Open Access 01-03-2018 | Review

Functional morphology of the blood–brain barrier in health and disease

Authors: Stefan Liebner, Rick M. Dijkhuizen, Yvonne Reiss, Karl H. Plate, Dritan Agalliu, Gabriela Constantin

Published in: Acta Neuropathologica | Issue 3/2018

Abstract

The adult quiescent blood–brain barrier (BBB), a structure organised by endothelial cells through interactions with pericytes, astrocytes, neurons and microglia in the neurovascular unit, is highly regulated but fragile at the same time. In the past decade, there has been considerable progress in understanding not only the molecular pathways involved in BBB development, but also BBB breakdown in neurological diseases. Specifically, the Wnt/β-catenin, retinoic acid and sonic hedgehog pathways moved into the focus of BBB research. Moreover, angiopoietin/Tie2 signalling that is linked to angiogenic processes has gained attention in the BBB field. Blood vessels play an essential role in initiation and progression of many diseases, including inflammation outside the central nervous system (CNS). Therefore, the potential influence of CNS blood vessels in neurological diseases associated with BBB alterations or neuroinflammation has become a major focus of current research to understand their contribution to pathogenesis. Moreover, the BBB remains a major obstacle to pharmaceutical intervention in the CNS. The complications may either be expressed by inadequate therapeutic delivery like in brain tumours, or by poor delivery of the drug across the BBB and ineffective bioavailability. In this review, we initially describe the cellular and molecular components that contribute to the steady state of the healthy BBB. We then discuss BBB alterations in ischaemic stroke, primary and metastatic brain tumour, chronic inflammation and Alzheimer’s disease. Throughout the review, we highlight common mechanisms of BBB abnormalities among these diseases, in particular the contribution of neuroinflammation to BBB dysfunction and disease progression, and emphasise unique aspects of BBB alteration in certain diseases such as brain tumours. Moreover, this review highlights novel strategies to monitor BBB function by non-invasive imaging techniques focussing on ischaemic stroke, as well as novel ways to modulate BBB permeability and function to promote treatment of brain tumours, inflammation and Alzheimer’s disease. In conclusion, a deep understanding of signals that maintain the healthy BBB and promote fluctuations in BBB permeability in disease states will be key to elucidate disease mechanisms and to identify potential targets for diagnostics and therapeutic modulation of the BBB.

Abadier M, Haghayegh Jahromi N, Cardoso Alves L, Boscacci R, Vestweber D, Barnum S, Deutsch U, Engelhardt B, Lyck R (2015) Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood–brain barrier. Eur J Immunol 45:1043–1058. https://doi.org/10.1002/eji.201445125 PubMedCrossRef

Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D (2008) Dynamic analysis of the blood–brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging. Mol Imaging 7:248–262. https://doi.org/10.2310/7290.2008.00025 PubMed

Agarwal R, Brunelli SM, Williams K, Mitchell MD, Feldman HI, Umscheid CA (2009) Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 24:856–863. https://doi.org/10.1093/ndt/gfn593 PubMedCrossRef

Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G (2017) Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aak9679

Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, van Horssen J, de Vries HE, Charron F, Prat A (2011) The hedgehog pathway promotes blood–brain barrier integrity and CNS immune quiescence. Science 334:1727–7731. https://doi.org/10.1126/science.1206936 PubMedCrossRef

Alvarez JI, Saint-Laurent O, Godschalk A, Terouz S, Briels C, Larouche S, Bourbonnière L, Larochelle C, Prat A (2015) Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis 74:14–24. https://doi.org/10.1016/j.nbd.2014.09.016 PubMedCrossRef

Aubé B, Lévesque SA, Paré A, Chamma É, Kebir H, Gorina R, Lécuyer M-A, Alvarez JI, De Koninck Y, Engelhardt B, Prat A, Côté D, Lacroix S (2014) Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases. J Immunol 193:2438–2454. https://doi.org/10.4049/jimmunol.1400401 PubMedCrossRef

Avraham HK, Jiang S, Fu Y, Nakshatri H, Ovadia H, Avraham S (2014) Angiopoietin-2 mediates blood–brain barrier impairment and colonization of triple-negative breast cancer cells in brain. J Pathol 232:369–381. https://doi.org/10.1002/path.4304 PubMedCrossRef

Baeten KM, Akassoglou K (2011) Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke. Dev Neurobiol 71:1018–1039. https://doi.org/10.1002/dneu.20954 PubMedPubMedCentralCrossRef

10.

Banerjee S, Bhat MA (2007) Neuron-glial interactions in blood–brain barrier formation. Annu Rev Neurosci 30:235–258. https://doi.org/10.1146/annurev.neuro.30.051606.094345 PubMedPubMedCentralCrossRef

11.

Bauer S, van Alphen N, Becker A, Chiocchetti A, Deichmann R, Deller T, Freiman T, Freitag CM, Gehrig J, Hermsen AM, Jedlicka P, Kell C, Klein KM, Knake S, Kullmann DM, Liebner S, Norwood BA, Omigie D, Plate K, Reif A, Reif PS, Reiss Y, Roeper J, Ronellenfitsch MW, Schorge S, Schratt G, Schwarzacher SW, Steinbach JP, Strzelczyk A, Triesch J, Wagner M, Walker MC, von Wegner F, Rosenow F (2017) Personalized translational epilepsy research—novel approaches and future perspectives: part II: experimental and translational approaches. Epilepsy Behav. https://doi.org/10.1016/j.yebeh.2017.06.040

12.

Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C (2014) Mfsd2a is critical for the formation and function of the blood–brain barrier. Nature. https://doi.org/10.1038/nature13324 PubMedPubMedCentral

13.

Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin Y-C, Zamudio F, Hernandez LD, Sabbagh JJ, Selenica M-LB, Dickey CA (2015) Tau depletion prevents progressive blood–brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun 3:8. https://doi.org/10.1186/s40478-015-0186-2 PubMedPubMedCentralCrossRef

14.

Borjini N, Fernández M, Giardino L, Calzà L (2016) Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis. J Neuroinflammation 13:291. https://doi.org/10.1186/s12974-016-0757-6 PubMedPubMedCentralCrossRef

15.

Bouts MJ, Tiebosch IA, Rudrapatna US, van der Toorn A, Wu O, Dijkhuizen RM (2017) Prediction of hemorrhagic transformation after experimental ischemic stroke using MRI-based algorithms. J Cereb Blood Flow Metab 37:3065–3076. https://doi.org/10.1177/0271678X16683692 PubMedCrossRef

16.

Buckwalter MS, Coleman BS, Buttini M, Barbour R, Schenk D, Games D, Seubert P, Wyss-Coray T (2006) Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer’s mice overproducing transforming growth factor-beta 1. J Neurosci 26:11437–11441. https://doi.org/10.1523/JNEUROSCI.2436-06.2006 PubMedPubMedCentralCrossRef

17.

Campbell M, Humphries P (2012) The blood-retina barrier: tight junctions and barrier modulation. Adv Exp Med Biol 763:70–84. https://doi.org/10.1007/978-1-4614-4711-5-3 PubMed

18.

Campochiaro PA, Peters KG (2016) Targeting Tie2 for treatment of diabetic retinopathy and diabetic macular edema. Curr Diabetes Rep 16:126. https://doi.org/10.1007/s11892-016-0816-5 CrossRef

19.

Carlson T, Kroenke M, Rao P, Lane TE, Segal B (2008) The Th17-ELR + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 205:811–823. https://doi.org/10.1084/jem.20072404 PubMedPubMedCentralCrossRef

20.

Carman CV, Martinelli R (2015) T Lymphocyte–endothelial interactions: emerging understanding of trafficking and antigen-specific immunity. Front Immunol 6:603. https://doi.org/10.3389/fimmu.2015.00603 PubMedPubMedCentralCrossRef

21.

Carrano A, Hoozemans JJM, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJM (2012) Neuroinflammation and blood–brain barrier changes in capillary amyloid angiopathy. Neuro Degener Dis 10:329–331. https://doi.org/10.1159/000334916 CrossRef

22.

Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, Prat A (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 9:137–145. https://doi.org/10.1038/ni1551 PubMedCrossRef

23.

Chen J, Luo Y, Hui H, Cai T, Huang H, Yang F, Feng J, Zhang J, Yan X (2017) CD146 coordinates brain endothelial cell-pericyte communication for blood–brain barrier development. Proc Natl Acad Sci 4:201710848. https://doi.org/10.1073/pnas.1710848114

24.

Cheslow L, Alvarez JI (2016) Glial-endothelial crosstalk regulates blood–brain barrier function. Curr Opin Pharmacol 26:39–46. https://doi.org/10.1016/j.coph.2015.09.010 PubMedCrossRef

25.

Cho C, Smallwood PM, Nathans J (2017) Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-specific signaling in mammalian CNS angiogenesis and blood–brain barrier regulation. Neuron. https://doi.org/10.1016/j.neuron.2017.07.031

26.

Chow BW, Gu C (2017) Gradual suppression of transcytosis governs functional blood-retinal barrier formation. Neuron 93(1325–1333):e3. https://doi.org/10.1016/j.neuron.2017.02.043

27.

Daneman R, Engelhardt B (2017) Brain barriers in health and disease. Neurobiol Dis 107:1–3. https://doi.org/10.1016/j.nbd.2017.05.008 PubMedCrossRef

28.

Deddens LH, Van Tilborg GAF, Mulder WJM, de Vries HE, Dijkhuizen RM (2012) Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Cerebrovasc Dis 33:392–402. https://doi.org/10.1159/000336116 PubMedCrossRef

29.

Dejana E, Orsenigo F (2013) Endothelial adherens junctions at a glance. J Cell Sci 126:2545–2549. https://doi.org/10.1242/jcs.124529 PubMedCrossRef

30.

Desestret V, Brisset J-C, Moucharrafie S, Devillard E, Nataf S, Honnorat J, Nighoghossian N, Berthezène Y, Wiart M (2009) Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke 40:1834–1841. https://doi.org/10.1161/STROKEAHA.108.531269 PubMedCrossRef

31.

Deutsch U, Schlaeger TM, Dehouck B, Döring A, Tauber S, Risau W, Engelhardt B (2008) Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice. Exp Cell Res 314:1202–1216. https://doi.org/10.1016/j.yexcr.2007.12.026 PubMedCrossRef

32.

Dijkhuizen RM (2002) Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke 33:2100–2104. https://doi.org/10.1161/01.STR.0000023534.37670.F7 PubMedCrossRef

33.

Ebnet K, Brinkmann BF, Kummer D, Misselwitz S, Peddibhotla SSD, Tuncay H (2013) Tight Junctions, Junctional Adhesion Molecules (JAMs), and the Blood Brain Barrier. In: Martin TA, Jiang WG (eds) Tight Junctions in Cancer Metastasis. Springer, Netherlands, Dordrecht, p 313

34.

Elyaman W, Khoury SJ (2017) Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol 39:79–87. https://doi.org/10.1007/s00281-016-0604-y PubMedCrossRef

35.

Engelhardt B, Liebner S (2014) Novel insights into the development and maintenance of the blood–brain barrier. Cell Tissue Res 355:687–699. https://doi.org/10.1007/s00441-014-1811-2 PubMedPubMedCentralCrossRef

36.

Erickson MA, Banks WA (2013) Blood–brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J Cereb Blood Flow Metab 33:1500–1513. https://doi.org/10.1038/jcbfm.2013.135 PubMedPubMedCentralCrossRef

37.

Ewing JR, Knight RA, Nagaraja TN, Yee JS, Nagesh V, Whitton PA, Li L, Fenstermacher JD (2003) Patlak plots of Gd-DTPA MRI data yield blood–brain transfer constants concordant with those of 14C-sucrose in areas of blood–brain opening. Magn Reson Med 50:283–292. https://doi.org/10.1002/mrm.10524 PubMedCrossRef

38.

Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC (2008) Blood–brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci 105:15511–15516. https://doi.org/10.1073/pnas.0807656105 PubMedPubMedCentralCrossRef

39.

Ferrara N, Adamis AP (2016) Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov 15:385–403. https://doi.org/10.1038/nrd.2015.17 PubMedCrossRef

40.

Ferretti MT, Merlini M, Spani C, Gericke C, Schweizer N, Enzmann G, Engelhardt B, Kulic L, Suter T, Nitsch RM (2016) T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer’s disease-like cerebral amyloidosis. Brain Behav Immun 54:211–225. https://doi.org/10.1016/j.bbi.2016.02.009 PubMedCrossRef

41.

Glatigny S, Duhen R, Oukka M, Bettelli E (2011) Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells. J Immunol 187:6176–6179. https://doi.org/10.4049/jimmunol.1102515 PubMedPubMedCentralCrossRef

42.

Goswami D, März S, Li Y-T, Artz A, Schäfer K, Seelige R, Pacheco-Blanco M, Jing D, Bixel MG, Araki M, Araki K, Yamamura K-I, Vestweber D (2017) Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs. Blood 129:1811–1822. https://doi.org/10.1182/blood-2016-08-733394 PubMedCrossRef

43.

Gurnik S, Devraj K, Macas J, Yamaji M, Starke J, Scholz A, Sommer K, Di Tacchio M, Vutukuri R, Beck H, Mittelbronn M, Foerch C, Pfeilschifter W, Liebner S, Peters KG, Plate KH, Reiss Y (2016) Angiopoietin-2-induced blood–brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol 131:753–773. https://doi.org/10.1007/s00401-016-1551-3 PubMedPubMedCentralCrossRef

44.

Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, Zlokovic BV (2016) Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 36:216–227. https://doi.org/10.1038/jcbfm.2015.44 PubMedPubMedCentralCrossRef

45.

Hambardzumyan D, Bergers G (2015) Glioblastoma: defining tumor niches. Trends Cancer 1:252–265. https://doi.org/10.1016/j.trecan.2015.10.009 PubMedPubMedCentralCrossRef

46.

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013 PubMedCrossRef

47.

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405. https://doi.org/10.1016/S1474-4422(15)70016-5 PubMedCrossRef

48.

Heye AK, Thrippleton MJ, Armitage PA, Valdés Hernández MDC, Makin SD, Glatz A, Sakka E, Wardlaw JM (2016) Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability. Neuroimage 125:446–455. https://doi.org/10.1016/j.neuroimage.2015.10.018 PubMedPubMedCentralCrossRef

49.

Hjort N, Wu O, Ashkanian M, Sølling C, Mouridsen K, Christensen S, Gyldensted C, Andersen G, Østergaard L (2008) MRI detection of early blood–brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke 39:1025–1028. https://doi.org/10.1161/STROKEAHA.107.497719 PubMedCrossRef

50.

Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994–1998. https://doi.org/10.1126/science.284.5422.1994 PubMedCrossRef

51.

Holopainen T, Saharinen P, D’Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Helotera H, Tammela T, Benjamin LE, Ylä-Herttuala S, Leow CC, Koh GY, Alitalo K (2012) Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104:461–475. https://doi.org/10.1093/jnci/djs009 PubMedPubMedCentralCrossRef

52.

Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CRW (2010) Cellular mechanisms of IL-17-induced blood–brain barrier disruption. FASEB J 24:1023–1034. https://doi.org/10.1096/fj.09-141978 PubMedCrossRef

53.

Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S (2005) Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171:939–945. https://doi.org/10.1083/jcb.200510043 PubMedPubMedCentralCrossRef

54.

Ilhan-Mutlu A, Osswald M, Liao Y, Gömmel M, Reck M, Miles D, Mariani P, Gianni L, Lutiger B, Nendel V, Srock S, Perez-Moreno P, Thorsen F, von Baumgarten L, Preusser M, Wick W, Winkler F (2016) Bevacizumab prevents brain metastases formation in lung adenocarcinoma. Mol Cancer Ther 15:702–710. https://doi.org/10.1158/1535-7163.MCT-15-0582 PubMedCrossRef

55.

Jiang Q, Zhang ZG, Ding GL, Zhang L, Ewing JR, Wang L, Zhang R, Li L, Lu M, Meng H, Arbab AS, Hu J, Li QJ, Pourabdollah Nejad DS, Athiraman H, Chopp M (2005) Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 28:698–707. https://doi.org/10.1016/j.neuroimage.2005.06.063 PubMedCrossRef

56.

Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, Sharp FR (2014) Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab 34:185–199. https://doi.org/10.1038/jcbfm.2013.203 PubMedCrossRef

57.

Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nat Med 13:1173–1175. https://doi.org/10.1038/nm1651 PubMedPubMedCentralCrossRef

58.

Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate KH, Machein MR (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res 68:7342–7351. https://doi.org/10.1158/0008-5472.CAN-07-6241 PubMedCrossRef

59.

Kerfoot SM, Kubes P (2002) Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 169:1000–1006. https://doi.org/10.4049/jimmunol.169.2.1000 PubMedCrossRef

60.

Klohs J, Steinbrink J, Bourayou R, Mueller S, Cordell R, Licha K, Schirner M, Dirnagl U, Lindauer U, Wunder A (2009) Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood–brain barrier impairment after focal cerebral ischemia in mice. J Neurosci Methods 180:126–132. https://doi.org/10.1016/j.jneumeth.2009.03.002 PubMedCrossRef

61.

Knight RA, Nagesh V, Nagaraja TN, Ewing JR, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD (2005) Acute blood–brain barrier opening in experimentally induced focal cerebral ischemia is preferentially identified by quantitative magnetization transfer imaging. Magn Reson Med 54:822–832. https://doi.org/10.1002/mrm.20630 PubMedCrossRef

62.

Knowland D, Arac A, Sekiguchi KJ, Hsu M, Lutz SE, Perrino J, Steinberg GK, Barres BA, Nimmerjahn A, Agalliu D (2014) Stepwise recruitment of transcellular and paracellular pathways underlies blood–brain barrier breakdown in stroke. Neuron 82:603–617. https://doi.org/10.1016/j.neuron.2014.03.003 PubMedPubMedCentralCrossRef

63.

Kook S-Y, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I (2012) Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood–brain barrier via Ca²⁺-calcineurin signaling. J Neurosci 32:8845–8854. https://doi.org/10.1523/JNEUROSCI.6102-11.2012 PubMedCrossRef

64.

Kronstein R, Seebach J, Großklaus S, Minten C, Engelhardt B, Drab M, Liebner S, Arsenijevic Y, Taha AA, Afanasieva T, Schnittler H-J (2012) Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res 93:130–140. https://doi.org/10.1093/cvr/cvr256 PubMedCrossRef

65.

Larochelle C, Cayrol R, Kebir H, Alvarez JI, Lécuyer M-A, Ifergan I, Viel É, Bourbonnière L, Beauseigle D, Terouz S, Hachehouche L, Gendron S, Poirier J, Jobin C, Duquette P, Flanagan K, Yednock T, Arbour N, Prat A (2012) Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 135:2906–2924. https://doi.org/10.1093/brain/aws212 PubMedCrossRef

66.

Latour LL, Kang D-W, Ezzeddine MA, Chalela JA, Warach S (2004) Early blood–brain barrier disruption in human focal brain ischemia. Ann Neurol 56:468–477. https://doi.org/10.1002/ana.20199 PubMedCrossRef

67.

Lemus HN, Warrington A, Rodriguez M (2018) Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin 36:1–11. https://doi.org/10.1016/j.ncl.2017.08.002 PubMedCrossRef

68.

Lewis CE, Harney AS, Pollard JW (2016) The multifaceted role of perivascular macrophages in tumors. Cancer Cell 30:18–25. https://doi.org/10.1016/j.ccell.2016.05.017 PubMedPubMedCentralCrossRef

69.

Lécuyer M-A, Saint-Laurent O, Bourbonnière L, Larouche S, Larochelle C, Michel L, Charabati M, Abadier M, Zandee S, Haghayegh Jahromi N, Gowing E, Pittet C, Lyck R, Engelhardt B, Prat A (2017) Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis. Proc Natl Acad Sci 114:E524–E533. https://doi.org/10.1073/pnas.1614336114 PubMedPubMedCentralCrossRef

70.

Li M, Shang D-S, Zhao W-D, Tian L, Li B, Fang W-G, Zhu L, Man S-M, Chen Y-H (2009) Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood–brain barrier. J Immunol 182:5778–5788. https://doi.org/10.4049/jimmunol.0803013 PubMedCrossRef

71.

Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK (2007) Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 28:1292–1298. https://doi.org/10.3174/ajnr.A0539 PubMedCrossRef

72.

Liu D-F, Qian C, An Y-L, Chang D, Ju S-H, Teng G-J (2014) Magnetic resonance imaging of post-ischemic blood–brain barrier damage with PEGylated iron oxide nanoparticles. Nanoscale 6:15161–15167. https://doi.org/10.1039/c4nr03942d PubMedCrossRef

73.

Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, Bohn KA, Adkins CE, Roberts A, Thorsheim HR, Gaasch JA, Huang S, Palmieri D, Steeg PS, Smith QR (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16:5664–5678. https://doi.org/10.1158/1078-0432.CCR-10-1564 PubMedPubMedCentralCrossRef

74.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, Deimling von A (2016) WHO Classification of Tumours of the Central Nervous System, 4 ed. International Agency for Research on Cancer

75.

Lueg G, Gross CC, Lohmann H, Johnen A, Kemmling A, Deppe M, Groger J, Minnerup J, Wiendl H, Meuth SG, Duning T (2015) Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer’s disease. Neurobiol Aging 36:81–89. https://doi.org/10.1016/j.neurobiolaging.2014.08.008 PubMedCrossRef

76.

Lutz SE, Smith JR, Kim DH, Olson CVL, Ellefsen K, Bates JM, Gandhi SP, Agalliu D (2017) Caveolin1 is required for Th1 cell infiltration, but not tight junction remodeling, at the blood–brain barrier in autoimmune neuroinflammation. Cell Rep 21:2104–2117. https://doi.org/10.1016/j.celrep.2017.10.094 PubMedPubMedCentralCrossRef

77.

Man S-M, Ma Y-R, Shang D-S, Zhao W-D, Li B, Guo D-W, Fang W-G, Zhu L, Chen Y-H (2007) Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer’s disease. Neurobiol Aging 28:485–496. https://doi.org/10.1016/j.neurobiolaging.2006.02.013 PubMedCrossRef

78.

Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR, Raleigh DR, Guan Y, Watson AJM, Montrose MH, Turner JR (2010) Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189:111–126. https://doi.org/10.1083/jcb.200902153 PubMedPubMedCentralCrossRef

79.

Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, Furuse M (2011) LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 124:548–555. https://doi.org/10.1242/jcs.072058 PubMedCrossRef

80.

Merali Z, Huang K, Mikulis D, Silver F, Kassner A (2017) Evolution of blood–brain-barrier permeability after acute ischemic stroke. PLoS ONE 12:e0171558. https://doi.org/10.1371/journal.pone.0171558 PubMedPubMedCentralCrossRef

81.

Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol 122:293–311. https://doi.org/10.1007/s00401-011-0834-y PubMedPubMedCentralCrossRef

82.

Mo R, Chen J, Han Y, Bueno-Cannizares C, Misek DE, Lescure PA, Hanash S, Yung RL (2003) T cell chemokine receptor expression in aging. J Immunol 170:895–904. https://doi.org/10.4049/jimmunol.170.2.895 PubMedCrossRef

83.

Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer’s disease: a matter of blood–brain barrier dysfunction? J Exp Med. https://doi.org/10.1084/jem.20171406 PubMed

84.

Motz GT, Coukos G (2013) Deciphering and reversing tumor immune suppression. Immunity 39:61–73. https://doi.org/10.1016/j.immuni.2013.07.005 PubMedPubMedCentralCrossRef

85.

Murphy AC, Lalor SJ, Lynch MA, Mills KHG (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24:641–651. https://doi.org/10.1016/j.bbi.2010.01.014 PubMedCrossRef

86.

Nael K, Knitter JR, Jahan R, Gornbein J, Ajani Z, Feng L, Meyer BC, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Liebeskind DS, Guzy J, Starkman S, Saver JL, Kidwell CS (2017) Multiparametric magnetic resonance imaging for prediction of parenchymal hemorrhage in acute ischemic stroke after reperfusion therapy. Stroke 48:664–670. https://doi.org/10.1161/STROKEAHA.116.014343 PubMedPubMedCentralCrossRef

87.

Naert G, Rivest S (2013) A deficiency in CCR2 + monocytes: the hidden side of Alzheimer’s disease. J Mol Cell Biol 5:284–293. https://doi.org/10.1093/jmcb/mjt028 PubMedCrossRef

88.

Osswald M, Blaes J, Liao Y, Solecki G, Gommel M, Berghoff AS, Salphati L, Wallin JJ, Phillips HS, Wick W, Winkler F (2016) Impact of blood–brain barrier integrity on tumor growth and therapy response in brain metastases. Clin Cancer Res 22:6078–6087. https://doi.org/10.1158/1078-0432.CCR-16-1327 PubMedCrossRef

89.

Osterberg N, Ferrara N, Vacher J, Gaedicke S, Niedermann G, Weyerbrock A, Doostkam S, Schaefer H-E, Plate KH, Machein MR (2016) Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model. NeuroOncol 18:939–949. https://doi.org/10.1093/neuonc/now005

90.

Park J-S, Kim I-K, Han S, Park I, Kim C, Bae J, Oh SJ, Lee S, Kim JH, Woo D-C, He Y, Augustin HG, Kim I, Lee D, Koh GY (2016) Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment. Cancer Cell 30:953–967. https://doi.org/10.1016/j.ccell.2016.10.018 PubMedCrossRef

91.

Pierson ER, Wagner CA, Goverman JM (2016) The contribution of neutrophils to CNS autoimmunity. Clin Immunol. https://doi.org/10.1016/j.clim.2016.06.017 PubMedPubMedCentral

92.

Pietronigro E, Zenaro E, Constantin G (2016) Imaging of leukocyte trafficking in Alzheimer’s disease. Front Immunol 7:33. https://doi.org/10.3389/fimmu.2016.00033 PubMedPubMedCentralCrossRef

93.

Pietronigro EC, Bianca Della V, Zenaro E, Constantin G (2017) NETosis in Alzheimer’s disease. Front in Immunol 8:211. https://doi.org/10.3389/fimmu.2017.00211 CrossRef

94.

Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D (2016) Corticosteroids compromise survival in glioblastoma. Brain 139:1458–1471. https://doi.org/10.1093/brain/aww046 PubMedPubMedCentralCrossRef

95.

Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848. https://doi.org/10.1038/359845a0 PubMedCrossRef

96.

Prager O, Chassidim Y, Klein C, Levi H, Shelef I, Friedman A (2010) Dynamic in vivo imaging of cerebral blood flow and blood–brain barrier permeability. Neuroimage 49:337–344. https://doi.org/10.1016/j.neuroimage.2009.08.009 PubMedCrossRef

97.

Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, Wegner A, Wyss-Coray T, Heppner FL (2015) Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease-like mice. J Exp Med 212:1811–1818. https://doi.org/10.1084/jem.20150479 PubMedPubMedCentralCrossRef

98.

Quail DF, Joyce JA (2017) The Microenvironmental landscape of brain tumors. Cancer Cell 31:326–341. https://doi.org/10.1016/j.ccell.2017.02.009 PubMedCrossRef

99.

Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344. https://doi.org/10.1056/NEJMra0909142 PubMedCrossRef

100.

Reis M, Czupalla CJ, Ziegler N, Devraj K, Zinke J, Seidel S, Heck R, Thom S, Macas J, Bockamp E, Fruttiger M, Taketo MM, Dimmeler S, Plate KH, Liebner S (2012) Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 209:1611–1627. https://doi.org/10.1084/jem.20111580 PubMedPubMedCentralCrossRef

101.

Reiss Y, Scholz A, Plate KH (2015) The angiopoietin—tie system: common signaling pathways for angiogenesis. Cancer Inflamm. https://doi.org/10.1007/978-1-4939-2907-8_13

102.

Ridder DA, Wenzel J, Muller K, Tollner K, Tong X-K, Assmann JC, Stroobants S, Weber T, Niturad C, Fischer L, Lembrich B, Wolburg H, Grand’Maison M, Papadopoulos P, Korpos E, Truchetet F, Rades D, Sorokin LM, Schmidt-Supprian M, Bedell BJ, Pasparakis M, Balschun D, D’Hooge R, Löscher W, Hamel E, Schwaninger M (2015) Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. J Exp Med 212:1529–1549. https://doi.org/10.1084/jem.20150165 PubMedPubMedCentralCrossRef

103.

Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE (1998) Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153:1239–1248. https://doi.org/10.1016/S0002-9440(10)65668-4 PubMedPubMedCentralCrossRef

104.

Rost NS, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJ, Lauer A, Etherton MR, Karadeli HH, Musolino PL, Copen WA, Arai K, Lo EH, Feske SK, Furie KL, Wu O (2017) Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke. J Cereb Blood Flow Metab 88:2716781X7706449. https://doi.org/10.1177/0271678X17706449

105.

Rothhammer V, Heink S, Petermann F, Srivastava R, Claussen MC, Hemmer B, Korn T (2011) Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J Exp Med 208:2465–2476. https://doi.org/10.1084/jem.20110434 PubMedPubMedCentralCrossRef

106.

Saharinen P, Eklund L, Alitalo K (2017) Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov. https://doi.org/10.1038/nrd.2016.278 PubMed

107.

Scalzo F, Alger JR, Hu X, Saver JL, Dani KA, Muir KW, Demchuk AM, Coutts SB, Luby M, Warach S, Liebeskind DS, STIR, VISTA Imaging Investigators (2013) Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging 31:961–969. https://doi.org/10.1016/j.mri.2013.03.013 PubMedPubMedCentralCrossRef

108.

Schmittnaegel M, Rigamonti N, Kadioglu E, Cassará A, Wyser Rmili C, Kiialainen A, Kienast Y, Mueller H-J, Ooi C-H, Laoui D, De Palma M (2017) Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aak9670 PubMed

109.

Schoknecht K, Prager O, Vazana U, Kamintsky L, Harhausen D, Zille M, Figge L, Chassidim Y, Schellenberger E, Kovács R, Heinemann U, Friedman A (2014) Monitoring stroke progression: in vivo imaging of cortical perfusion, blood–brain barrier permeability and cellular damage in the rat photothrombosis model. J Cereb Blood Flow Metab 34:1791–1801. https://doi.org/10.1038/jcbfm.2014.147 PubMedPubMedCentralCrossRef

110.

Scholz A, Harter PN, Cremer S, Yalcin BH, Gurnik S, Yamaji M, Di Tacchio M, Sommer K, Baumgarten P, Bähr O, Steinbach JP, Trojan J, Glas M, Herrlinger U, Krex D, Meinhardt M, Weyerbrock A, Timmer M, Goldbrunner R, Deckert M, Braun C, Schittenhelm J, Frueh JT, Ullrich E, Mittelbronn M, Plate KH, Reiss Y (2016) Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med 8:39–57. https://doi.org/10.15252/emmm.201505505 PubMedCrossRef

111.

Simmons SB, Liggitt D, Goverman JM (2014) Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J Immunol 193:555–563. https://doi.org/10.4049/jimmunol.1400807 PubMedPubMedCentralCrossRef

112.

Simpkins AN, Dias C, National Institutes of Health Natural History of Stroke Investigators (2016) Identification of reversible disruption of the human blood–brain barrier following acute ischemia. Stroke 47:2405–2408. https://doi.org/10.1161/STROKEAHA.116.013805 PubMedPubMedCentralCrossRef

113.

Sisó S, Jeffrey M, González L (2010) Sensory circumventricular organs in health and disease. Acta Neuropathol 120:689–705. https://doi.org/10.1007/s00401-010-0743-5 PubMedCrossRef

114.

Sohet F, Lin C, Munji RN, Lee SY, Ruderisch N, Soung A, Arnold TD, Derugin N, Vexler ZS, Yen FT, Daneman R (2015) LSR/angulin-1 is a tricellular tight junction protein involved in blood–brain barrier formation. J Cell Biol 208:703–711. https://doi.org/10.1083/jcb.201410131 PubMedPubMedCentralCrossRef

115.

Sonar SA, Lal G (2017) Differentiation and transmigration of CD4 T cells in neuroinflammation and autoimmunity. Front Immunol. https://doi.org/10.3389/fimmu.2017.01695 PubMedPubMedCentral

116.

Sonar SA, Shaikh S, Joshi N, Atre AN, Lal G (2017) IFN-γ promotes transendothelial migration of CD4 + T cells across the blood–brain barrier. Immunol Cell Biol 95:843–853. https://doi.org/10.1038/icb.2017.56 PubMedCrossRef

117.

Sourbron SP, Buckley DL (2013) Classic models for dynamic contrast-enhanced MRI. NMR Biomed 26:1004–1027. https://doi.org/10.1002/nbm.2940 PubMedCrossRef

118.

Späni C, Suter T, Derungs R, Ferretti MT, Welt T, Wirth F, Gericke C, Nitsch RM, Kulic L (2015) Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells. Acta Neuropathol Commun 3:71. https://doi.org/10.1186/s40478-015-0251-x PubMedPubMedCentralCrossRef

119.

Stamatovic SM, Keep RF, Wang MM, Jankovic I, Andjelkovic AV (2009) Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem 284:19053–19066. https://doi.org/10.1074/jbc.M109.000521 PubMedPubMedCentralCrossRef

120.

Stankovic ND, Teodorczyk M, Ploen R, Zipp F, Schmidt MHH (2015) Microglia–blood vessel interactions: a double-edged sword in brain pathologies. Acta Neuropathol 131:347–363. https://doi.org/10.1007/s00401-015-1524-y CrossRef

121.

Stomrud E, Björkqvist M, Janciauskiene S, Minthon L, Hansson O (2010) Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res Ther 2:20. https://doi.org/10.1186/alzrt44 PubMedPubMedCentralCrossRef

122.

Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459–1466. https://doi.org/10.1016/S0002-9440(10)65733-1 PubMedPubMedCentralCrossRef

123.

Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM (2008) Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14:337–342. https://doi.org/10.1038/nm1715 PubMedPubMedCentralCrossRef

124.

Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19:771–783. https://doi.org/10.1038/nn.4288 PubMedPubMedCentralCrossRef

125.

Szigeti K, Horváth I, Veres DS, Martinecz B, Lénárt N, Kovács N, Bakcsa E, Márta A, Semjéni M, Máthé D, Dénes Á (2015) A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia. J Cereb Blood Flow Metab 35:1921–1929. https://doi.org/10.1038/jcbfm.2015.174 PubMedPubMedCentralCrossRef

126.

Tietz S, Engelhardt B (2015) Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol 209:493–506. https://doi.org/10.1083/jcb.201412147 PubMedPubMedCentralCrossRef

127.

Underly RG, Levy M, Hartmann DA, Grant RI, Watson AN, Shih AY (2017) Pericytes as inducers of rapid, matrix metalloproteinase-9-dependent capillary damage during ischemia. J Neurosci 37:129–140. https://doi.org/10.1523/JNEUROSCI.2891-16.2016 PubMedPubMedCentralCrossRef

128.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE (2015) Overcoming the blood–brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat 19:1–12. https://doi.org/10.1016/j.drup.2015.02.002 PubMedCrossRef

129.

Vanhollebeke B, Stone OA, Bostaille N, Cho C, Zhou Y, Maquet E, Gauquier A, Cabochette P, Fukuhara S, Mochizuki N, Nathans J, Stainier DY (2015) Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/β-catenin pathway during brain angiogenesis. Elife 4:e06489. https://doi.org/10.7554/eLife.06489 PubMedCentralCrossRef

130.

Villringer K, Sanz Cuesta BE, Ostwaldt A-C, Grittner U, Brunecker P, Khalil AA, Schindler K, Eisenblätter O, Audebert H, Fiebach JB (2017) DCE-MRI blood–brain barrier assessment in acute ischemic stroke. Neurology 88:433–440. https://doi.org/10.1212/WNL.0000000000003566 PubMedCrossRef

131.

Wan W, Cao L, Liu L, Zhang C, Kalionis B, Tai X, Li Y, Xia S (2015) Aβ(1-42) oligomer-induced leakage in an in vitro blood–brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem 134:382–393. https://doi.org/10.1111/jnc.13122 PubMedCrossRef

132.

Wang J, Fernández-Seara MA, Wang S, St Lawrence KS (2007) When perfusion meets diffusion: in vivo measurement of water permeability in human brain. J Cereb Blood Flow Metab 27:839–849. https://doi.org/10.1038/sj.jcbfm.9600398 PubMedCrossRef

133.

Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies G, Sontheimer H (2014) Disruption of astrocyte-vascular coupling and the blood–brain barrier by invading glioma cells. Nat Commun 5:4196. https://doi.org/10.1038/ncomms5196 PubMedPubMedCentralCrossRef

134.

Wilhelm I, Nyúl-Tóth Á, Suciu M, Hermenean A, Krizbai IA (2016) Heterogeneity of the blood–brain barrier. Tissue Barriers 4:e1143544. https://doi.org/10.1080/21688370.2016.1143544 PubMedPubMedCentralCrossRef

135.

Winger RC, Harp CT, Chiang M-Y, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA (2016) Cutting edge: CD99 is a novel therapeutic target for control of T cell-mediated central nervous system autoimmune disease. J Immunol 196:1443–1448. https://doi.org/10.4049/jimmunol.1501634 PubMedPubMedCentralCrossRef

136.

Winger RC, Koblinski JE, Kanda T, Ransohoff RM, Muller WA (2014) Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood–brain barrier. J Immunol 193:2427–2437. https://doi.org/10.4049/jimmunol.1400700 PubMedPubMedCentralCrossRef

137.

Wolburg H, Noell S, Fallier-Becker P, Mack AF, Wolburg-Buchholz K (2012) The disturbed blood–brain barrier in human glioblastoma. Mol Aspects Med 33:579–589. https://doi.org/10.1016/j.mam.2012.02.003 PubMedCrossRef

138.

Wu H, Deng R, Chen X, Wong WC, Chen H, Gao L, Nie Y, Wu W, Shen J (2016) Caveolin-1 is critical for lymphocyte trafficking into central nervous system during experimental autoimmune encephalomyelitis. J Neurosci 36:5193–5199. https://doi.org/10.1523/JNEUROSCI.3734-15.2016 PubMedCrossRef

139.

Wu S, Thornhill RE, Chen S, Rammo W, Mikulis DJ, Kassner A (2009) Relative recirculation: a fast, model-free surrogate for the measurement of blood–brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol 44:662–668. https://doi.org/10.1097/RLI.0b013e3181ae9c40 PubMedCrossRef

140.

Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, Thorsteinsson L, Suematsu N, Matsushita M, Otomo E (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27:1155–1162. https://doi.org/10.1161/01.STR.27.7.1155 PubMedCrossRef

141.

Yang W, Wu Q, Yuan C, Gao J, Xiao M, Gu M, Ding J, Hu G (2012) Aquaporin-4 mediates astrocyte response to beta-amyloid. Mol Cell Neurosci 49:406–414. https://doi.org/10.1016/j.mcn.2012.02.002 PubMedCrossRef

142.

Yang Y, Rosenberg GA (2011) Blood–brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42:3323–3328. https://doi.org/10.1161/STROKEAHA.110.608257 PubMedPubMedCentralCrossRef

143.

Zenaro E, Piacentino G, Constantin G (2017) The blood–brain barrier in Alzheimer’s disease. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2016.07.007 PubMedPubMedCentral

144.

Zenaro E, Pietronigro E, Bianca Della V, Piacentino G, Marongiu L, Budui S, Turano E, Rossi B, Angiari S, Dusi S, Montresor A, Carlucci T, Nanì S, Tosadori G, Calciano L, Catalucci D, Berton G, Bonetti B, Constantin G (2015) Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med 21:880–886. https://doi.org/10.1038/nm.3913 PubMedCrossRef

145.

Zhao Y-L, Song J-N, Zhang M (2014) Role of caveolin-1 in the biology of the blood–brain barrier. Rev Neurosci 25:247–254. https://doi.org/10.1515/revneuro-2013-0039 PubMedCrossRef

146.

Zheng S, Bai Y-Y, Changyi Y, Gao X, Zhang W, Wang Y, Zhou L, Ju S, Li C (2014) Multimodal nanoprobes evaluating physiological pore size of brain vasculatures in ischemic stroke models. Adv Healthc Mater 3:1909–1918. https://doi.org/10.1002/adhm.201400159 PubMedCrossRef

147.

Zhou Y, Nathans J (2014) Gpr124 controls CNS angiogenesis and blood–brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev Cell 31:248–256. https://doi.org/10.1016/j.devcel.2014.08.018 PubMedPubMedCentralCrossRef

148.

Zhou Y, Wang Y, Tischfield M, Williams J, Smallwood PM, Rattner A, Taketo MM, Nathans J (2014) Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest 124:3825–3846. https://doi.org/10.1172/JCI76431 PubMedPubMedCentralCrossRef

149.

Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain. J Neurochem 115:1077–1089. https://doi.org/10.1111/j.1471-4159.2010.07002.x PubMedPubMedCentralCrossRef

Title: Functional morphology of the blood–brain barrier in health and disease
Authors: Stefan Liebner
Rick M. Dijkhuizen
Yvonne Reiss
Karl H. Plate
Dritan Agalliu
Gabriela Constantin
Publication date: 01-03-2018
Publisher: Springer Berlin Heidelberg
Published in: Acta Neuropathologica / Issue 3/2018
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-018-1815-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Functional morphology of the blood–brain barrier in health and disease

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage

Cluster: barriers of the central nervous system

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)

RNA versus protein toxicity in C9orf72 ALS/FTLD

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway

The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS